1. Market Research
  2. > Healthcare Market Trends
  3. > Cameroon Pharmaceuticals and Healthcare Report Q3 2016

Cameroon Pharmaceuticals and Healthcare Report Q3 2016

  • May 2016
  • -
  • Business Monitor International
  • -
  • 50 pages

Includes 3 FREE quarterly updates

BMI View: Although Cameroon's economic growth is expected to remain on track driven by public-privatepartnerships in strategic infrastructure projects, the country's pharmaceutical and healthcare sector willremain dependent on private out-of-pocket spending and global aid funds, which will weigh on the sector'spotential over the forecast period. That said, international efforts to implement universal health coverage,as well as local initiatives in e-health and health coverage arrangements, will contribute in supporting thehealthcare sector development and gradually improve access to treatment.

Headline Expenditure Projections

- Pharmaceuticals: XAF217.14bn (USD360mn) in 2015 to XAF238.26bn (USD390mn) in 2016; +9.7%in local currency terms and +6.7% in US dollar terms. Forecast revised downwards from last quarter.

- Healthcare: XAF694.42bn (USD1.16bn) in 2015 to XAF728.06bn (USD1.19bn) in 2016; +4.9% in localcurrency terms and +2.0% in US dollar terms. Forecast revised downwards from last quarter.

Table Of Contents

Cameroon Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Cameroon 2014-2020) 7
SWOT 9
Industry Forecast 10
Pharmaceutical Market Forecast 10
Table: Pharmaceutical Sales, Historical Data And Forecasts (Cameroon 2012-2020) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Cameroon 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Cameroon 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Cameroon 2012-2020) 18
Industry Risk Reward Index 19
Middle East and Africa Risk/Reward Index - Q3 2016 19
Cameroon Risk/Reward Index 27
Rewards 27
Risks 27
Regulatory Review 29
Market Overview 31
Healthcare Sector 32
Epidemiology 33
Competitive Landscape 36
Research-Based Industry 36
Table: Multinational Market Activity 38
Demographic Forecast 39
Table: Population Headline Indicators (Cameroon 1990-2025) 40
Table: Key Population Ratios (Cameroon 1990-2025) 40
Table: Urban/Rural Population and Life Expectancy (Cameroon 1990-2025) 41
Table: Population By Age Group (Cameroon 1990-2025) 41
Table: Population By Age Group % (Cameroon 1990-2025) 42
Glossary 44
Methodology 46
Pharmaceutical Expenditure Forecast Model 46
Healthcare Expenditure Forecast Model 46
Notes On Methodology 47
Risk/Reward Index Methodology 48
Index Overview 49
Table: Pharmaceutical Risk/Reward Index Indicators 49
Indicator Weightings 50

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Psoriatic Arthritis Pricing, Reimbursement, and Access

Psoriatic Arthritis Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • June 2016
  • by Datamonitor Healthcare

An absence of head-to-head trials, along with biosimilar launches, provide payers with leverage to demand favorable pricing for branded products in exchange for formulary access. This report addresses ...

Wound Care Market by Product, Surgical, Traditional, Wound Type, Acute, End User, Long-Term Care, Home Healthcare - Global Forecast to 2021

Wound Care Market by Product, Surgical, Traditional, Wound Type, Acute, End User, Long-Term Care, Home Healthcare - Global Forecast to 2021

  • $ 7 150
  • Industry report
  • May 2016
  • by MarketsandMarkets

The wound care market in terms of value is expected to reach USD 20.4 billion by 2021 from USD 17.0 billion in 2016, growing at a CAGR of 3.6% from 2016 to 2021. This market is categorized on the basis ...

MediPoint: Rheumatoid Arthritis Testing - Global Analysis and Market Forecasts

MediPoint: Rheumatoid Arthritis Testing - Global Analysis and Market Forecasts

  • $ 5 995
  • Industry report
  • June 2016
  • by Global Data

MediPoint: Rheumatoid Arthritis Testing - Global Analysis and Market Forecasts Summary Rheumatoid Arthritis (RA) is the commonest autoimmune disease in humans. The disease is prevalent in all ethnic groups, ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.